Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
Authors
Pierre Fenaux,
Ghulam MuftiEva Hellström‐Lindberg,
Valeria Santini,
Carlo Finelli,
Aristoteles Giagounidis,
María Odero,
Norbert Vey,
Guillermo Sanz,
Alan List,
Steven Gore,
John Seymour,
John Bennett,
John Byrd,
Jay Backstrom,
Linda Zimmerman,
David McKenzie,
C.L. Beach,
Lewis Silverman,
Robert Schoch +18 authors
,
Norbert Gattermann Tip Tip